As modern medicine develops, it increasingly relies on technological advancements. One of the more recent and major examples of this is Microsoft's collaboration with NVIDIA to bring the power of generative artificial intelligence ("AI"), the cloud and accelerated computing to healthcare and life sciences organizations. The use of cutting edge software is geared towards revolutionizing patient care to make it more precise and accessible for global users.
One example is BioNeMo, an AI platform for drug discovery that accelerates the training of models on proprietary data and scales the deployment of models for drug discovery applications. This software is aimed at helping scientists identify drug candidates more quickly and accurately.
The development of AI-based imaging is another aspect of the collaboration between Microsoft and NVIDIA that promises to revolutionize current healthcare practices. The combination of the power of Microsoft Azure, NVIDIA's Medical Open Network for AI, and the Nuance Precision Imaging Network enables safe and effective development, validation, deployment and evaluation of medical imaging AI models at scale. The aim of this development is to reduce the time needed for research data preparation, representing a leap towards AI-driven medical breakthroughs.
The content of this article does not constitute legal advice and should not be relied on in that way. Specific advice should be sought about your specific circumstances.